Month: <span>January 2022</span>

Home / 2022 / January
Synthetic antibody demonstrates Omicron detection along with all other variants of concern
Post

Synthetic antibody demonstrates Omicron detection along with all other variants of concern

Jan 14 2022 Reviewed by Danielle Ellis, B.Sc. Bedford, UK | 13th January 2022 – MIP Diagnostics Ltd. has today announced that its synthetic SARS-CoV-2 antibody (COVID-19 nanoMIPTM) can detect the Omicron variant as well as previously proven Alpha, Beta, Delta, and Gamma variants of the COVID-19 virus. MIP Diagnostics, the leading manufacturer of molecularly imprinted...

‘Ghost’ viruses offer potentially better approach to gene editing
Post

‘Ghost’ viruses offer potentially better approach to gene editing

12 JAN 2022 BY ROBERT F. SERVICE Not every human disease can be tackled with a pill or shot. Some disorders would ideally be treated by delivering molecular payloads—like modified viruses carrying gene-editing tools—into defective cells, where they could rewrite target genes. Despite some early successes, researchers are still struggling to get this approach to...

Post

Insulin-producing cells grown from stem cells are safe for transplant: study

Diabetes researchers are reporting early success in a first-in-humans clinical trial to test whether pancreatic cells grown from stem cells can be safely implanted and begin to produce insulin. The team reported on their proof of concept and safety study in a newly published paper in the journal Cell Reports Medicine.  Of 17 patients who received implants, 35 percent...

Cancer Immunotherapy Treatment Developed by Purdue Researchers
Post

Cancer Immunotherapy Treatment Developed by Purdue Researchers

Zhong-Yin Zhang of Purdue’s College of Pharmacy and his team of researchers have developed a cancer immunotherapy. The novel lead compound showed no in vivo side effects and leads to reduced tumor growth in mice studies. Zhong-Yin Zhang. Photo provided by Zhong-Yin Zhang / Purdue University Researchers in Purdue University’s College of Pharmacy are further...

Post

COVID: why T cell vaccines could be the key to long-term immunity

With omicron having rapidly driven up COVID infections, attention is once again focusing on antibodies, and reasonably so. They play a critical role in fighting off viruses and are important for preventing the coronavirus infecting our cells. This is why some countries have mounted booster campaigns in response to recent COVID surges – to top...

Magnetic-Plasmonic Hybrid Nanoparticles Isolate Lysosomes from Cells
Post

Magnetic-Plasmonic Hybrid Nanoparticles Isolate Lysosomes from Cells

JANUARY 13TH, 2022  CONN HASTINGS  ETC., GENETICS, NANOMEDICINE, PATHOLOGY Researchers at the Japan Advanced Institute of Science and Technology have developed a method to isolate intact lysosomes from cells. The technique is rapid and produces samples of high purity. Lysosomes are the garbage-disposal organelles within a cell, and they are involved in numerous diseases, from lysosomal storage...

Post

Heart disease causes early brain dysfunction and can treble key Alzheimer’s protein

UNIVERSITY OF SHEFFIELD •     Scientists have discovered that heart disease causes brain dysfunction that could lead to dementia before the buildup of plaque in blood vessels of the brain•    Heart disease causes problems in the brain that causes less blood to reach the neurons that need it •    Findings also show that a combination of...

Post

Dried goji berries may provide protection against age-related vision loss

UNIVERSITY OF CALIFORNIA – DAVIS Regularly eating a small serving of dried goji berries may help prevent or delay the development of age-related macular degeneration, or AMD, in healthy middle-aged people, according to a small, randomized trial conducted at the University of California, Davis. AMD is the leading cause of vision loss in older people, and is estimated...

Study finds hydroxychloroquine delays disability for least treatable form of multiple sclerosis
Post

Study finds hydroxychloroquine delays disability for least treatable form of multiple sclerosis

UNIVERSITY OF CALGARY VIDEO: A UCALGARY STUDY HAS FOUND PROMISING RESULTS FOR THE GENERIC DRUG HYDROXYCHLOROQUINE WHEN USED TO REDUCE THE WORSENING OF DISABILITY OF PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS (MS), THE LEAST TREATABLE FORM OF THE AUTOIMMUNE DISEASE. MS AFFECTS ABOUT 90,000 CANADIANS, ONE OF THE HIGHEST RATES IN THE WORLD WITH ABOUT 15 PER...

Post

Compost is a major source of pathogenic aspergillus spores

AMERICAN SOCIETY FOR MICROBIOLOGY Washington, D.C. – January 13. 2022 – Fourteen percent of Aspergillus fumigatus isolates cultured from garden soils were resistant to an agricultural triazole antifungal drug, tebuconazole. Tebuconazole resistance confers resistance to medical triazoles that are used to treat aspergillosis, a lung infection that can be serious, which results from inhalation of A. fumigatus spores. The research is published...